Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × Heavy Ion Radiotherapy × Clear all

NCT04143984 2022-04-29

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma